Today's Nifty Pharma Index Price
The Nifty Pharma Index today, May 22, 2025, concluded the trading session on a negative note, reflecting the broader bearish sentiment prevalent in the Indian stock market. The Nifty Pharma share price (closing value) settled at Rs. 21,480.75, marking a decrease of Rs. 242.90, or 1.12%, from its previous close of Rs. 21,723.65. Throughout the day, the Nifty Pharma Index live feed showed fluctuations, with the index trading within a range of Rs. 21,465.65 and Rs. 21,741.70 before closing lower.
For the most current, regularly updated Nifty Pharma Index share price, please refer to the live ticker section located above on this page. That section provides a real-time share price summary, including the top gainer loser stocks daily.
Nifty Pharma Index Historical Returns
The historical returns for the Nifty Pharma Index as of the closing on May 22, 2025, (adjusted for the day's performance based on previous day's closing data from ET) are as follows:
- 1 Week: +0.01%
- 1 Month: +0.61%
- 3 Months: +5.37%
- 6 Months: -1.20%
- 1 Year: +11.85%
(Returns are as of May 22, 2025, calculated by adjusting returns data as of May 21, 2025, with the index's performance on May 22, 2025.)
An analysis of the Nifty Pharma Index performance indicates a mixed trend. While the index has delivered strong positive returns over the past year and three months, the six-month and more recent short-term figures (including today's fall) suggest a period of consolidation or volatility. The India stock market index performance, including that of the Pharma sector, is being shaped by a confluence of domestic earnings reports and global economic signals. The nifty pharma stocks list, comprising leading pharmaceutical companies, collectively dictates these trends.
Nifty Pharma Index News and Updates
Several key developments around May 22, 2025, have influenced the Nifty Pharma Index news and the sentiment for nifty pharma today:
-
Broader Market Weakness Impacts Pharma: The Nifty Pharma Index declined by 1.12% on May 22, 2025, mirroring the overall negative trend in the Indian equity markets. This market-wide sell-off was primarily attributed to weak global cues, including concerns about U.S. fiscal health and rising U.S. Treasury yields, which prompted caution among investors across various sectors.
-
Optimistic FY26 Outlook Despite Daily Volatility: Interestingly, despite the day's downturn, the pharmaceutical sector has been generating positive buzz. Recent reports highlighted an optimistic outlook for FY26, driven by solid Q4 earnings from several prominent drugmakers and positive management commentaries. Factors such as the U.S. decision to exclude generic drugs from its pricing policy and anticipated growth in the Indian Pharmaceutical Market (IPM) are seen as supportive for the sector's medium-term prospects.
-
Stock-Specific Action and Earnings Focus: Individual constituents of the Nifty Pharma Index saw varied movements. On May 22, stocks like Mankind Pharma, Biocon, and Alkem Laboratories were among the notable losers, while Zydus Lifesciences registered gains. The ongoing Q4 corporate earnings season remains a critical factor, with results from major players like Sun Pharmaceutical Industries keenly awaited on this day. These company-specific outcomes are crucial in shaping investor sentiment towards the factors affecting Nifty Pharma Index.
Investors are advised to keep a close watch on these evolving narratives, corporate earnings, and global economic trends to make informed decisions regarding the Nifty Pharma Index.